Status:
ACTIVE_NOT_RECRUITING
Part II: Exercise in Hispanic Breast Cancer Survivors
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
21+ years
Phase:
NA
Brief Summary
The goal of this research study is to test an exercise program that is designed for Hispanic breast cancer survivors. Researchers want to learn the most effective strategies for promoting exercise.
Detailed Description
Study Summary: If you are found to be eligible to take part in this study, you will come in for 2 visits to complete fitness testing and questionnaires at the Behavioral Research Treatment Center (BR...
Eligibility Criteria
Inclusion
- Be Female and be 21 years of age or older. (Pilot Test and PreTest Criteria)
- Self-reported Mexican-American ( for Mexican-American participants) or Puerto Rican ethnicity. (Pilot Test and PreTest Criteria)
- History of breast cancer (invasive or ductal carcinoma in situ). (Pilot Test Criteria only)
- At least 3 months post treatment (surgery, chemotherapy, radiation). (Pilot Test Criteria only)
- Not meeting current recommended physical activity guidelines. (Pilot Test and PreTest Criteria)
- Able to read/write in either English or Spanish. (Pilot Test and PreTest Criteria)
- Reside in Harris County, Texas or one of the contiguous counties or metropolitan area of San Juan, Puerto Rico. (Pilot Test and PreTest Criteria)
- Be able to provide informed consent. (Pilot Test and PreTest Criteria)
- Be oriented to person, place, and time. (Pilot Test and PreTest Criteria)
Exclusion
- Currently receiving Herceptin or non-hormonal treatment for cancer (hormonal treatment is allowed). (Pilot Test and PreTest Criteria)
- Present with any of American College of Sports Medicine's absolute contraindications to exercise testing: (A recent significant change in the resting ECG suggesting significant ischemia, recent myocardial infarction (within 2 days), or other acute cardiac event; unstable angina; uncontrolled cardiac dysrhythmias causing symptoms or hemodynamic compromise; symptomatic severe aortic stenosis; uncontrolled symptomatic heart failure; acute pulmonary embolus or pulmonary infarction; acute myocarditis or pericarditis; suspected or known dissecting aneurysm acute systemic infection, accompanied by fever, body aches, or swollen lymph glands). ( Pilot Test and PreTest Criteria)
Key Trial Info
Start Date :
February 7 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2026
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01504789
Start Date
February 7 2012
End Date
February 28 2026
Last Update
October 27 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
2
University of Puerto Rico
San Juan, Puerto Rico, 00936